CONCEPT MAPPİNG AND GAMİFİCATİON İN ARTERİAL BLOOD GAS ANALYSİS EDUCATİON (NCT07611851) | Clinical Trial Compass
CompletedNot Applicable
CONCEPT MAPPİNG AND GAMİFİCATİON İN ARTERİAL BLOOD GAS ANALYSİS EDUCATİON
Turkey (Türkiye)90 participantsStarted 2026-01-01
Plain-language summary
This randomized controlled study aims to examine the effect of a concept mapping and gamification-based educational approach on arterial blood gas analysis skills among first-year anesthesia program students. The study will be conducted with students enrolled in the Anesthesia Program of a Vocational School of Health Services. Participants will be randomly assigned to an intervention group or a control group. The intervention group will receive concept mapping and gamification-based arterial blood gas analysis training, while the control group will receive traditional education through lecture, slide presentation, and written materials. The primary outcome is students' arterial blood gas analysis knowledge and interpretation skills, measured using the Arterial Blood Gas Analysis Knowledge Test. Secondary outcomes include problem-solving skills and decision-making styles. Data will be collected before the intervention, immediately after the education, and three months after the education to assess retention.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Voluntary agreement to participate in the study
* Being a first-year student in the Anesthesia Program
* Ability to understand and speak Turkish
* Using a mobile device with Android v5.0 or higher or iOS v9.0 or higher operating system
Exclusion Criteria:
* Having previously completed another undergraduate degree before enrollment in the Anesthesia Program
* Having previously received arterial blood gas analysis education in any educational program
* Failure to complete the post-test or retention test assessments
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Arterial Blood Gas Analysis Knowledge and Interpretation Skills
Timeframe: Baseline, immediately after the intervention, and 3 months after the intervention